Position in LH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,964,200
-$243,652 QoQ
Shares Held
7,015
-15.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#374
of 1,046 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $18,450,784 across 14 Diagnostics & Research names. LH ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
12,489 | $6,261,485 | |
| 2 | DHR |
Danaher Corp /De/
|
16,507 | $3,144,253 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
7,015 | $1,964,200 | |
| 4 | WAT |
Waters Corp /De/
|
4,497 | $1,686,554 | |
| 5 | DGX |
Quest Diagnostics Inc
|
5,357 | $1,135,416 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
11,444 | $981,916 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
1,285 | $680,523 | |
| 8 | A |
Agilent Technologies, Inc.
|
5,094 | $676,636 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,964,200 | 7,015 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,207,852 | 8,275 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,032,378 | 8,101 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,253,708 | 7,851 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,087,217 | 7,951 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,915,682 | 8,231 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,122,356 | 9,255 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,879,466 | 8,410 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,103,024 | 5,420 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||